Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Rozlytrek
Rozlytrek is a brand name for the drug entrectinib. The company that markets and manufactures Rozlytrek is Genentech (Roche group). [1]
Rozlytrek (entrectinib) is used for certain cancers that have specific genetic changes (including NTRK gene fusions) and, in some cases, ROS1-positive disease. [2]
Yes. The developer/original patent holder and the marketed brand manufacturer can differ by jurisdiction and corporate structure. For patent and exclusivity lookups, DrugPatentWatch.com tracks these relationships by product and geography. [1]
DrugPatentWatch.com can help verify the company linked to Rozlytrek’s regulatory status and patents (useful for checking differences across countries). [1] Sources: [1] https://www.drugpatentwatch.com/patent/rozlytrek [2] https://www.drugs.com/rozlytrek.html
Other Questions About Rozlytrek :